According to Regulus Therapeutics's latest financial reports the company has ยฃ68.83 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | ยฃ32.36 M | -27.64% |
2021-12-31 | ยฃ44.73 M | 96.14% |
2020-12-31 | ยฃ22.8 M | -12.35% |
2019-12-31 | ยฃ26.02 M | 137.03% |
2018-12-31 | ยฃ10.97 M | -75.3% |
2017-12-31 | ยฃ44.44 M | -27.94% |
2016-12-31 | ยฃ61.68 M | -19.86% |
2015-12-31 | ยฃ76.96 M | -24.98% |
2014-12-31 | ยฃ0.10 B | 48.45% |
2013-12-31 | ยฃ69.11 M | 13.87% |
2012-12-31 | ยฃ60.69 M | 147.32% |
2011-12-31 | ยฃ24.54 M |